Development of venom toxin-specific antibodies by DNA immunisation: rationale and strategies to improve therapy of viper envenoming

Robert Harrison

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Abstract

DNA vaccination induces potent cellular immune responses against infectious and parasitic intracellular pathogens. This paper illustrates that DNA immunisation protocols can be adapted to induce high titre antibody responses with potential to improve the treatment of systemic snake envenoming that kills 20,000 people annually in Africa. Envenoming by the saw-scaled vipers and puff adders are responsible for the majority of these deaths. DNA sequences encoding haemorrhagic, pro- and anti-coagulant and other haemostasis-disruptive venom toxins from these vipers showed extensive cross-specific and cross-generic sequence and structural similarities. The predicted antigenic profiles of these toxin sequences are utilised to design DNA immunisation constructs to generate toxin-specific antibodies with potential to polyspecifically neutralise venoms from the most medically-important African vipers. (C) 2004 Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)1648-1655
Number of pages8
JournalVaccine
Volume22
Issue number13-14
DOIs
Publication statusPublished - 16 Apr 2004

Keywords

  • 2D SDS-PAGE
  • C-type lectin
  • CTL
  • Echis ocellatus
  • PCR
  • Phospholipase A
  • PLA
  • Polymerase chain reaction
  • Snake venom metalloproteinases
  • SVMPs
  • Two-dimensional sodium dodecyl sulphate polyacrylamide gel electrophoresis

Fingerprint

Dive into the research topics of 'Development of venom toxin-specific antibodies by DNA immunisation: rationale and strategies to improve therapy of viper envenoming'. Together they form a unique fingerprint.

Cite this